220 related articles for article (PubMed ID: 19801217)
1. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
Blake GM; Moore AE; Fogelman I
Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
[TBL] [Abstract][Full Text] [Related]
2. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
3. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
[TBL] [Abstract][Full Text] [Related]
4. Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment.
Moore AE; Blake GM; Taylor KA; Rana AE; Wong M; Chen P; Fogelman I
J Bone Miner Res; 2010 May; 25(5):960-7. PubMed ID: 19929434
[TBL] [Abstract][Full Text] [Related]
5. Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate.
Blake GM; Park-Holohan SJ; Fogelman I
J Nucl Med; 2002 Mar; 43(3):338-45. PubMed ID: 11884493
[TBL] [Abstract][Full Text] [Related]
6. Validation of ultrafiltration as a method of measuring free 99mTc-MDP.
Moore AE; Hain SF; Blake GM; Fogelman I
J Nucl Med; 2003 Jun; 44(6):891-7. PubMed ID: 12791815
[TBL] [Abstract][Full Text] [Related]
7. Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover?
Blake GM; Siddique M; Frost ML; Moore AE; Fogelman I
Bone; 2011 Sep; 49(3):537-42. PubMed ID: 21689803
[TBL] [Abstract][Full Text] [Related]
8. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
Park-Holohan SJ; Blake GM; Fogelman I
Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
[TBL] [Abstract][Full Text] [Related]
9. A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration.
Moore AE; Blake GM; Fogelman I
Nucl Med Commun; 2007 Mar; 28(3):187-92. PubMed ID: 17264777
[TBL] [Abstract][Full Text] [Related]
10. Influence of low grade exercise on skeletal scintigraphy using Tc-99m methylene diphosphonate.
Amin A; El-Kareem MA; Yahia AB
Nucl Med Rev Cent East Eur; 2015; 18(2):61-4. PubMed ID: 26315864
[TBL] [Abstract][Full Text] [Related]
11. Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
Mele M; Conte E; Fratello A; Pasculli D; Pieralice M; D'Addabbo A
J Nucl Med; 1983 Apr; 24(4):334-8. PubMed ID: 6834136
[TBL] [Abstract][Full Text] [Related]
12. (99m)Tc-HEPIDA hepatic clearance as a diagnostic tool: usefulness of a single sample plasma and hepatic clearance of (99m)Tc-HEPIDA for assessment of hepatic parenchyma performance.
Surma MJ; Frieske I; Jencz K; Kuźmierek J
Nucl Med Rev Cent East Eur; 2006; 9(2):125-31. PubMed ID: 17304475
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m hydroxymethylene diphosphonate and Tc-99m methylene diphosphonate: biological and clinical comparison: concise communication.
Littlefield JL; Rudd TG
J Nucl Med; 1983 Jun; 24(6):463-6. PubMed ID: 6222166
[TBL] [Abstract][Full Text] [Related]
14. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
15. New bone-seeking agent: animal study of Tc-99m-incadronate.
Shigematsu M; Shomi S; Iwao H; Ochi H
Ann Nucl Med; 2002 Feb; 16(1):55-9. PubMed ID: 11922209
[TBL] [Abstract][Full Text] [Related]
16. A direct in vivo measurement of 99mTc-methylene diphosphonate protein binding.
Blake GM; Moore AE; Park-Holohan SJ; Fogelman I
Nucl Med Commun; 2003 Jul; 24(7):829-35. PubMed ID: 12813203
[TBL] [Abstract][Full Text] [Related]
17. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
[TBL] [Abstract][Full Text] [Related]
18. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
19. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.
Hyldstrup L; McNair P; Ring P; Henriksen O
Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991
[TBL] [Abstract][Full Text] [Related]
20. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
